Meilleures Cliniques pour Thérapie par cellules souches pour la paralysie cérébrale

Le Prof. Gursel Turgut apporte 30 ans d'expérience en chirurgie plastique et reconstructrice à la thérapie par cellules souches pour la paralysie cérébrale. Le traitement individualisé peut coûter environ 9 500 à 12 500 $, couvrant généralement le programme thérapeutique, une nuit d'hospitalisation, l'hébergement en hôtel 4 étoiles et les transferts. Des protocoles spécifiques de cellules souches sont utilisés pour les cas complexes, avec un dépistage par IRM requis avant l'intervention. En tant que chirurgien plasticien doté d'une formation spécialisée, le Prof. Turgut se concentre sur des solutions pédiatriques sur mesure.

RE:YOUTH is the only institution in Korea specializing in arterial stem cell therapy in partnership with Yonsei BH Clinic. Unlike traditional intravenous (IV) injections, this innovative arterial method delivers 100% of stem cells directly to targeted organs, including the brain, heart, liver, pancreas, and kidneys, ensuring superior therapeutic outcomes.

This breakthrough approach holds the potential for treating conditions such as Parkinson’s disease, dementia, diabetes, erectile dysfunction (ED), liver cirrhosis, and kidney failure. RE:YOUTH offers a private, patient-centered experience with expert medical coordination, providing top-tier care for international patients seeking advanced regenerative treatments in Korea.

The Demarest Clinic offers regenerative medicine and cellular therapies, including treatments with amniotic fluid, mesenchymal stem cells derived from umbilical cord tissue, PRP (platelet-rich plasma), oxygen therapy, and Weber Laser IV therapy. The clinic is equipped with a satellite medical laboratory and an IV (intravenous) lounge. Its processes for culturing, preserving, and activating cells are certified by The American Association of Blood Banks (AABB).

The clinic focuses on achieving positive treatment outcomes and continuously updating protocols through a global network of researchers. Demarest prioritizes advancements in cellular medicine to improve health and prevent disease.